Document ID: chunk:federal_register_of_legislation:F2024N01149:schedule:3:p2
Version: federal_register_of_legislation:F2024N01149
Segment Type: schedule
Provision Reference: sch 3 (pt 2/2)
Character Range: 35820–39241

to identify the pharmaceutical benefit, including the name, pharmaceutical dose, form and strength, expressed as 'medicine/form/strength'; and
                     2.                 date of prescribing; and
                     3.               dose; and
                     4.               route of administration; and
                     5.                  frequency of administration; and
                     6.               prescriber details to satisfy paragraph 6 of Schedule 1.
                (d)                 The information for a variable dose pharmaceutical benefit must include:
                     1.                   particulars sufficient to identify the pharmaceutical benefit, including the name, pharmaceutical dose, form and strength, expressed as 'medicine/form/strength'; and
                     2.                 date of prescribing; and
                     3.               dose; and
                     4.               route of administration; and
                     5.                  frequency of administration; and
                     6.               prescriber details to satisfy paragraph 6 of Schedule 1.

      5.      Recently Ceased Pharmaceutical Benefits

            5.1               The copy of a chart requirements for recently ceased pharmaceutical benefits within the current chart duration must include the following:
                (a)                 particulars sufficient to identify the pharmaceutical benefit, including the name, pharmaceutical dose, form and strength, expressed as 'medicine/form/strength'; and
                (b)                 dose; and
                (c)                 route of administration;
                (d)                 frequency of administration; and
                (e)                 prescriber details to satisfy paragraph 6 of Schedule 1; and
                (f)                  date ceased; and
                (g)                 reason for cessation (if known).

      6.      Pharmaceutical Benefit Administration

            6.1               The copy of a chart requirements for all pharmaceutical benefit administration must include the following:
                (a)                 commencement date; and
                (b)                 cessation date; and
                (c)                 administration considerations.

      7.      Nutritional Supplements

            7.1               The copy of a chart requirements for a pharmaceutical benefit that is a nutritional supplement must include the following:
                (a)                 particulars sufficient to identify the pharmaceutical benefit, including the name and strength, expressed as 'nutritional supplement'; and
                (b)                 date of prescribing; and
                (c)                 dose; and
                (d)                 route of administration; and
                (e)                 frequency of administration; and
                (f)                  prescriber details to satisfy paragraph 6 of Schedule1.

      8.      Period of validity

            8.1               For the 72-hour period of validity of a copy of an electronic medication chart, each page of the copy must include the following details of the chart:
                (a)                 commencement time and date of the copy; and
                (b)                 expiry time and date of the copy.